Suchergebnisse - "Li, Yanying"

PubPharm (6)

1

Real-world clinical analysis in 190 advanced NSCLC patients with uncommon EGFR mutations : A multi-center study

enthalten in: Cancer science | 2023

von Qin, Y. | Long, Y. | Tang, Y. | +15

2

Applicability of the adjusted graded prognostic assessment for lung cancer with brain metastases using molecular markers (Lung-molGPA) in a Chinese cohort : A retrospective study of multiple institutions

enthalten in: Cancer medicine | 2020

von Zhang, T. | Zhang, Y. | Zhou, L. | +21

3

Durable complete response after afatinib and crizotinib in an advanced non-small cell lung cancer patient with EGFR L861Q mutation and acquired MET amplification : a case report

enthalten in: Annals of palliative medicine | 2020

von Long, Y. | Zhang, K. | Li, Y. | +3

4

Progression of malignant pleural effusion during the early stage of gefitinib treatment in advanced EGFR-mutant lung adenocarcinoma involving complex driver gene mutations

enthalten in: Signal transduction and targeted therapy | 2020

von Liu, N. | Yu, M. | Yin, T. | +7

5

Progression of Central Nervous System Metastases in Advanced Nonsmall Cell Lung Cancer Patients Effectively Treated with First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor

enthalten in: Cancer biotherapy & radiopharmaceuticals | 2018

von Yu, M. | Zhao, Q. | Li, Y. | +12

6

Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors for lung squamous carcinomas harboring EGFR mutation : A multicenter study and pooled analysis of published reports

enthalten in: Oncotarget | 2017

von Liu, Y. | Zhang, Y. | Zhang, L. | +15

1
[1]